BioSpace News Archive

Policy

PhRMA CEO Calls Passage of Inflation Reduction Act a “Tragic Loss for Patients”

The Inflation Reduction Act, which is expected to have wide-ranging implications for the pharmaceutical industry, will still need to go to the House of Representatives.

August 8, 2022
·
4 min read
·
Mark Terry
Drug Development

Tufts’ Ken Getz: Onerous Clinical Trial Protocols Contribute to High Failure Rates

Industry executives often lament the fact that clinical trials take a long time to complete and often fail. BioSpace spoke with Tufts’ Ken Getz about possible reasons and solutions.

August 8, 2022
·
5 min read
·
Gail Dutton
Drug Development

Despite Slowing Disease Progression, Amgen’s Lung Cancer Studies Show High Liver Toxicity

Results from two Amgen studies on Lumakras for lung cancer showed its ability to slow disease progression, although combining it with immunotherapy increased the risk for TRAEs.

August 8, 2022
·
3 min read
·
Vanessa Doctor, RN
Deals

Pfizer Doubles Down on Sickle Cell Disease with $5.4B Global Blood Therapeutics Buy

Pfizer announced Monday that it is acquiring the hematology-focused company for $5.4 billion in order to bolster its presence in the multi-billion dollar rare disease market.

August 8, 2022
·
3 min read
·
Alex Keown
Drug Development

Karuna’s KarXT Drug Could Signal New Hope for Schizophrenia - Updated

Karuna Therapeutics released results from the Phase III EMERGENT-2 trial showing that KarXT, its lead candidate, can strongly reduce symptom severity in schizophrenia patients.

August 8, 2022
·
3 min read
·
Tristan Manalac
A Question of Life and Death: Yale Scientists Bring Pig Organs Back to Life

If replicated in humans, this technology could prolong organ health during major surgeries and improve the availability of donor organs.

August 8, 2022
·
3 min read
·
Tristan Manalac
Business

Do Q2 Results and Increased M&A Indicate a Recovery for Biotech?

A recent report predicts multiple acquisitions are set to be announced in the second half of the year, particularly by companies that have strong revenue streams from COVID-19 products.

August 8, 2022
·
3 min read
·
Alex Keown
Liposome Drug Delivery Market: Increase in Therapeutic and Diagnostic Applications to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global liposome drug delivery market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a considerable CAGR from 2019 to 2027.

August 8, 2022
·
6 min read
Shoulder Replacement Market is Driven by Rise in the Prevalence of Shoulder Arthritis to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global shoulder replacement market is expected to be valued at nearly US$ 4,000 Mn by 2027.

August 8, 2022
·
6 min read
The Parenteral Drugs Market Is Poised To Reach A Staggering Valuation Of US $ 802Bn By The End Of The 2029; States Fact.MR

Fact.MR – A Market Research and Competitive Intelligence Provider: The global parenteral drug market is expected to register growth during the forecast period.

August 8, 2022
·
7 min read